top of page


Lamelle Pharmaceuticals launches Matricoll ECM
A next-generation peptide-based oral supplement for comprehensive skin regeneration Lamelle Pharmaceuticals is redefining the skincare supplement category with the launch of Matricoll ECM® a premium, science-driven oral anti-ageing supplement engineered to repair, rebuild, and protect the skin from within. Leveraging advanced bio-active peptide technology, Matricoll ECM® offers a multi-targeted approach to extracellular matrix (ECM) regeneration, setting a new benchmark for
2 min read
bottom of page